NEW YORK (GenomeWeb News) – Myriad Genetics said after the close of the market on Tuesday that revenues for the first quarter of its Fiscal Year 2014 grew 52 percent year over year, aided by publicity surrounding Angelina Jolie's use of the BRACAnalysis test.

The Salt Lake City-based company posted revenues of $202.5 million for the three months ended Sept. 30, up from $133.4 million a year ago, and topping the average analyst estimate of $167.6 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.